Elevated serum γ-glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects

Diabetes Research and Clinical Practice

Volumn 84, Issue 2, 2009, Pages 152-157

  Shin, Jang Yel ^a   Chang, Sei Jin ^a   Shin, Young Goo ^a   Seo, Kwang Seok ^b   Chung, Choon Hee ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Health Science   (South Korea)

Author keywords

Glutamyltransferase; Adipokines; Insulin resistance; Visceral obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; RETINOL BINDING PROTEIN 4;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC PARAMETERS; OBESITY; WAIST CIRCUMFERENCE;

ADULT; AGED; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; RETINOL-BINDING PROTEINS, PLASMA; ROC CURVE;

EID: 63949086361     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.02.004     Document Type: Article

References (35)

1. Zimmet P., Boyko E.J., Collier G.R., and de Courten M. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann. N.Y. Acad. Sci. 892 (1999) 25-44
2. Meigs J.B., Rutter M.K., Sullivan L.M., Fox C.S., D'Agostino R.B., and Wilson P.W. Impact of insulin resistance on the risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 30 (2007) 1219-1225
3. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L.M., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
4. Cnop M., Landchild M.J., Vidal J., Havel P.J., Knowles N.G., Carr D.R., et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51 (2002) 1005-1015
5. Ross R., Freeman J., Hudson R., and Janssen I. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J. Clin. Endocrinol. Metab. 87 (2002) 5044-5051
6. Wagenknecht L.E., Langefeld C.D., Scherzinger A.L., Norris J.M., Haffner S.M., Saad M.F., et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 52 (2003) 2490-2496
7. Furler S.M., Gan S.K., Poynten A.M., Chisholm D.J., Campbell L.V., and Kriketos A.D. Relationship of adiponectin with insulin sensitivity in humans, independent of lipid availability. Obesity 14 (2006) 228-234
8. Norata G.D., Ongari M., Garlaschelli K., Raselli S., Grigore L., and Catapano A.L. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur. J. Endocrinol. 156 (2007) 279-284
9. Duncan B.B., Schmidt M.I., Pankow J.S., Bang H., Couper D., Ballantyne C.M., et al. Adiponectin and the development of type 2 diabetes: the Atherosclerosis Risk in Community Study. Diabetes 53 (2004) 2473-2478
10. Lyon C.J., Law R.E., and Hsueh W.A. Minireview: adipocity, inflammation, and atherogenesis. Endocrinology 144 (2003) 2195-2200
11. Schoen R.E., Thaete F.L., Sankey S.S., Weissfeld J.L., and Kuller L.H. Sagittal diameter in comparison with single slice CT as a predictor of total visceral adipose tissue volume. Int. J. Obes. Relat. Metab. Disord. 22 (1998) 338-342
12. Han T.S., Kelly I.E., Walsh K., Greene R.M., and Lean M.E. Relationship between volumes and areas from single transverse scans of intra-abdominal fat measured by magnetic resonance imaging. Int. J. Obes. Relat. Metab. Disord. 21 (1997) 1161-1166
13. Eguchi Y., Eguchi T., Mizuta T., Ide Y., Yasutake T., Iwakiri R., et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J. Gastroenterol. 41 (2006) 462-469
14. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
15. Angelico F., Ben M.D., Conti R., Francioso S., Feole K., Maccioni D., et al. Non-alcoholic liver disease: non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic disease. J. Gastroenterol. Hepatol. 18 (2003) 155-594
16. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann. Med. 37 (2005) 347-356
17. Vozarova B., Stefan N., Lindsay R.S., Saremi A., Pratley R.E., Bogardus C., et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51 (2002) 1889-1895
18. Hanley A.J., Williams K., Festa A., Wagenknecht L.E., D'Agostino Jr. R.B., Kempf J., et al. Elevations in markers of liver injury and risk of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 53 (2004) 2623-2632
19. Targher G., Bertolini L., Poli F., Rodella S., Scala L., Tessari R., et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54 (2005) 3541-3546
20. Targher G., Bertolini L., Padovani R., Rodella S., Tessari R., Zenari L., et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30 (2007) 1212-1218
21. Andre P., Balkau B., Vol S., Charles M.A., and Eschwege E. γ-Glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care 30 (2007) 2355-2361
22. Andre P., Balkau B., Born C., Charles M.A., and Eschwege E. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the DESIR cohort. Diabetologia 49 (2006) 2599-2603
23. Lee D.H., Ha M.H., Kim J.H., Christiani D.C., Gross M.D., Steffes M., et al. Gamma-glutamyltransferase and diabetes-a 4 year follow-up study. Diabetologia 46 (2003) 359-364
24. Ascaso J.F., Romero P., Real J.T., Lorente R.I., Martinez-Valls J., and Carmena R. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur. J. Intern. Med. 14 (2003) 101-106
25. Pouliot M.C., Despres J.P., Lemieux S., Moorjani S., Bouchard C., Tremblay A., et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am. J. Cardiol. 73 (1994) 460-468
26. Ferland M., Despres J.P., Tremblay A., Pinault S., Nadeau A., Moorjani S., et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br. J. Nutr. 61 (1989) 139-148
27. Stranges S., Dorn J.M., Muti P., Freudenheim J.L., Farinaro E., Russell M., et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 39 (2004) 754-763
28. Botton J., Heude B., Andre P., Bresson J.L., Ducimetiere P., and Charles M.A. Relationship between gamma-glutamyltransferase and fat mass in a general population of 8-17 years old children: the FLVS II study. Diabetes Metab. 33 (2007) 354-359
29. Iwasaki T. Hepatic fat content-independent association of the serum level of gamma-glutamyltransferase with visceral adiposity, but not subcutaneous adiposity. Diab. Res. Clin. Pract. 79 (2008) e13-e14
30. Wallace T.M., Utzschneider K.M., Tong J., Carr D.B., Zraika S., Bankson D.D., et al. Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat. Diabetes Care 30 (2007) 2673-2678
31. Ortega E., Koska J., Salbe A.D., Tataranni P.A., and Bunt J.C. Serum γ-glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children. J. Clin. Endocrinol. Metab. 91 (2006) 1419-1422
32. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436 (2005) 356-362
33. Stefan N., Hennige A.M., Staiger H., Machann J., Schick F., Schleicher E., et al. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 30 (2007) 1173-1178
34. Thamer C., Tschritter O., Haap M., Shirkavand F., Fritsche A., Schick F., et al. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm. Metab. Res. 37 (2005) 246-251
35. Wu H., Jia W., Bao Y., Lu J., Zhu J., Wang R., et al. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diab. Res. Clin. Pract. 79 (2008) 185-190